TY - JOUR
T1 - Pathogenic Potential of Hic1-Expressing Cardiac Stromal Progenitors
AU - Soliman, Hesham
AU - Paylor, Ben
AU - Scott, R. Wilder
AU - Lemos, Dario R.
AU - Chang, Chih Kai
AU - Arostegui, Martin
AU - Low, Marcela
AU - Lee, Christina
AU - Fiore, Daniela
AU - Braghetta, Paola
AU - Pospichalova, Vendula
AU - Barkauskas, Christina E.
AU - Korinek, Vladimir
AU - Rampazzo, Alessandra
AU - MacLeod, Kathleen
AU - Underhill, T. Michael
AU - Rossi, Fabio M.V.
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2020/2/6
Y1 - 2020/2/6
N2 - The cardiac stroma contains multipotent mesenchymal progenitors. However, lineage relationships within cardiac stromal cells are poorly defined. Here, we identified heart-resident PDGFRa+ SCA-1+ cells as cardiac fibro/adipogenic progenitors (cFAPs) and show that they respond to ischemic damage by generating fibrogenic cells. Pharmacological blockade of this differentiation step with an anti-fibrotic tyrosine kinase inhibitor decreases post-myocardial infarction (post-MI) remodeling and leads to improvement in cardiac function. In the undamaged heart, activation of cFAPs through lineage-specific deletion of the gene encoding the quiescence-associated factor HIC1 reveals additional pathogenic potential, causing fibrofatty infiltration within the myocardium and driving major pathological features pathognomonic in arrhythmogenic cardiomyopathy (AC). In this regard, cFAPs contribute to multiple pathogenic cell types within cardiac tissue and therapeutic strategies aimed at modifying their activity are expected to have tremendous benefit for the treatment of diverse cardiac diseases.
AB - The cardiac stroma contains multipotent mesenchymal progenitors. However, lineage relationships within cardiac stromal cells are poorly defined. Here, we identified heart-resident PDGFRa+ SCA-1+ cells as cardiac fibro/adipogenic progenitors (cFAPs) and show that they respond to ischemic damage by generating fibrogenic cells. Pharmacological blockade of this differentiation step with an anti-fibrotic tyrosine kinase inhibitor decreases post-myocardial infarction (post-MI) remodeling and leads to improvement in cardiac function. In the undamaged heart, activation of cFAPs through lineage-specific deletion of the gene encoding the quiescence-associated factor HIC1 reveals additional pathogenic potential, causing fibrofatty infiltration within the myocardium and driving major pathological features pathognomonic in arrhythmogenic cardiomyopathy (AC). In this regard, cFAPs contribute to multiple pathogenic cell types within cardiac tissue and therapeutic strategies aimed at modifying their activity are expected to have tremendous benefit for the treatment of diverse cardiac diseases.
KW - Hic1
KW - PDGFRa
KW - arrhythmogenic cardiomyopathy
KW - cFAP
KW - cardiac fibrosis
KW - fibroadipogenic progenitor
KW - fibrofatty infiltration
KW - mesenchymal progenitor
KW - myocardial infarction
KW - myocardial infarction
KW - nilotinib
UR - http://www.scopus.com/inward/record.url?scp=85078758564&partnerID=8YFLogxK
U2 - 10.1016/j.stem.2019.12.008
DO - 10.1016/j.stem.2019.12.008
M3 - Article
C2 - 31978365
AN - SCOPUS:85078758564
SN - 1934-5909
VL - 26
SP - 205-220.e8
JO - Cell Stem Cell
JF - Cell Stem Cell
IS - 2
ER -